FUNGUS FOR GENERATIONS


FUGENBIO

About us


With its innovative new material,
world-class R&D competency, and unique production technology, FUGENBiO does the best for customers’ healthy life and happiness

With the use of original material, the company develops health functional food product, medical product, and cosmetic product and provides the Total Solution for metabolic disease and anti-aging.

Core Material
Cosmetic Product
Health Functional Food Product
Medical Product

With the use of original material, the company develops health functional food product, medical product, and cosmetic product and provides the Total Solution for metabolic disease and anti-aging.

Cosmetic Product


· Functional cosmetic product with Ceriporia lacerata and natural substances
· Anti-aging, skin-reproduction and dermocosmetic
· Ceriporia lacerata's maximization of biological activity function
· Plan to sell finished products after the implementation of sales of cosmetic raw substances


Health Functional Food Product


· The 1st release of the health functional food product for blood-sugar control
· Establishment of marketing strategy based on efficacy
· Full-scale business performance after individual approval
· Improvements in blood pressure, liver function, immunity, and hyperlipidemia (complex function)
· Product diversification, including recovery from fatigue


Medical Product


· Enhanced R&D and Clinical Testing
· Development of medical products for treatment and prevention
· Medicine for diabetes
· Medicine for hypertension
· Medicine for cancer


history


history


heritage & discovery


“Ceriporia,” Gift of Nature Discovered by Accident

Fugenbio research team has made an important discovery from Ganoderma Applanatum gathered in Sang-Ju while gathering and analysing various fungi since 2005 to find natural ingredients that have anti-diabetic and anticancer effects.

While trying to find high quality starter cultures for the purpose of cultivating in artificial culture medium and industrializing Ganoderma Applanatum, which is recorded in Donguibogam (Principles and Practice of Eastern Medicine) to have a remarkable anti-diabetic effect, the research team found that the antidiabetic effect of the starter culture prepared in 2010 was outstanding and concluded that they have acquired the best starter culture.

Thus, as part of the commercialization procedure, the research team has requested that Korean Culture Center of Microorganisms (KCCM) take a DNA test of the starter culture. Quite unexpectedly however, the DNA test result indicated that the starter culture was in fact Ceriporia lacerata rather than Ganoderma Applanatum. That is, Ceriporia, a new microorganism having a symbiotic relationship with Ganoderma Applanatum, proliferated during artificial culture, and its effect was discovered by accident in the course of the research.

Fugenbio is doing its best to study the effectiveness of Ceriporia and to commercialize it with a sense of duty toward humanity so that this chance discovery could be usefully employed.

heritage & discovery


“Ceriporia,” Gift of Nature Discovered by Accident

Fugenbio research team has made an important discovery from Ganoderma Applanatum gathered in Sang-Ju while gathering and analysing various fungi since 2005 to find natural ingredients that have anti-diabetic and anticancer effects.

While trying to find high quality starter cultures for the purpose of cultivating in artificial culture medium and industrializing Ganoderma Applanatum, which is recorded in Donguibogam (Principles and Practice of Eastern Medicine) to have a remarkable anti-diabetic effect, the research team found that the antidiabetic effect of the starter culture prepared in 2010 was outstanding and concluded that they have acquired the best starter culture.

Thus, as part of the commercialization procedure, the research team has requested that Korean Culture Center of Microorganisms (KCCM) take a DNA test of the starter culture. Quite unexpectedly however, the DNA test result indicated that the starter culture was in fact Ceriporia lacerata rather than Ganoderma Applanatum. That is, Ceriporia, a new microorganism having a symbiotic relationship with Ganoderma Applanatum, proliferated during artificial culture, and its effect was discovered by accident in the course of the research.

Fugenbio is doing its best to study the effectiveness of Ceriporia and to commercialize it with a sense of duty toward humanity so that this chance discovery could be usefully employed.

“Ceriporia,” Gift of Nature Discovered by Accident

Fugenbio research team has made an important discovery from Ganoderma Applanatum gathered in Sang-Ju while gathering and analysing various fungi since 2005 to find natural ingredients that have anti-diabetic and anticancer effects.

While trying to find high quality starter cultures for the purpose of cultivating in artificial culture medium and industrializing Ganoderma Applanatum, which is recorded in Donguibogam (Principles and Practice of Eastern Medicine) to have a remarkable anti-diabetic effect, the research team found that the antidiabetic effect of the starter culture prepared in 2010 was outstanding and concluded that they have acquired the best starter culture.

Thus, as part of the commercialization procedure, the research team has requested that Korean Culture Center of Microorganisms (KCCM) take a DNA test of the starter culture. Quite unexpectedly however, the DNA test result indicated that the starter culture was in fact Ceriporia lacerata rather than Ganoderma Applanatum. That is, Ceriporia, a new microorganism having a symbiotic relationship with Ganoderma Applanatum, proliferated during artificial culture, and its effect was discovered by accident in the course of the research.

Fugenbio is doing its best to study the effectiveness of Ceriporia and to commercialize it with a sense of duty toward humanity so that this chance discovery could be usefully employed.

core competence


Possession of “REVOLUTIONARY” new substance

Based on the 'Ceriporia lacerata' found first in Korea, the new material 'CLEPS' was materialized. The excellent effects of CLEPS in the food and medical areas, and its efficacies in skin care area were verified.

Possession of “EXCLUSIVE IP”

With the application for domestic 18 patents, overseas patients, and PCT patents relating to food and medical fields and skin, the company secured the original patent of the effective substance 'CLEPS', and kept publishing theses in SCI-level journals, which draw attention in the academic circle.

Posession of “SPECIALIZED” techniques of microbial culture

The company secures CLEPS extraction technologies to maximize the effective substance, such as systematic control of mucor, fungi separation, concentration, mixture, and freeze-dry in order for strain loss prevention and stability security, and thereby establishes its specialized production system.

“DIFFERENTIATED” marketing & IT collaboration

Through IT-convergence marketing based on wearable device use, the company tries to provide intuitive service and benefits for the users in the u-health care and beauty care areas.